Viking Therapeutics (NASDAQ: VKTX) is a promising growth stock with a strong GLP-1 drug candidate in VK2735, which may ...
In a report released today, Mayank Mamtani from B.Riley Financial reiterated a Buy rating on Trevi Therapeutics (TRVI – Research Report), with ...
MarketBeat on MSN15h
3 Hot Stock Upgrades as Analysts Look Ahead to Q2 EarningsThe FQ4/CQ1 earnings reporting season is all but finished, leaving investors and analysts to look ahead at what will come ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback